RAFAEL HOLDINGS, INC. Revenue, Remaining Performance Obligation, Percentage
RAFAEL HOLDINGS, INC. (RFL) had Revenue, Remaining Performance Obligation, Percentage of 100.00% as of 2023-10-31, per its 10-Q filed 2023-12-14.
Discontinued › Notes
us-gaap:RevenueRemainingPerformanceObligationPercentage · last filed 2023-12-14
- 2023-10-31: Revenue, Remaining Performance Obligation, Percentage 100.00%.
- 2023-07-31: Revenue, Remaining Performance Obligation, Percentage 53.00%.
- 2022-10-31: Revenue, Remaining Performance Obligation, Percentage 22.00%.
- 2022-07-31: Revenue, Remaining Performance Obligation, Percentage 7.00%.
| Period end | Revenue, Remaining Performance Obligation, Percentage |
|---|---|
| 2023-10-31 | 100.00% 10-Q · filed 2023-12-14 |
| 2023-07-31 | 53.00% 10-K · filed 2023-10-30 |
| 2022-10-31 | 22.00% 10-Q · filed 2023-12-14 |
| 2022-07-31 | 7.00% 10-K · filed 2023-10-30 |
| 2021-10-31 | 7.00% 10-Q/A · filed 2022-02-28 |
| 2021-07-31 | 7.00% 10-K · filed 2022-10-31 |
| 2020-10-31 | 6.00% 10-Q/A · filed 2022-02-28 |
| 2020-07-31 | 6.00% 10-K · filed 2021-10-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |